|
| Number Eight, July 2002 - SPORTS MEDICINE & USAPL
SUSPENSION LIST
|
|
|
Dr. Michael Hartle
Medical Committee Chair
|
Drug Testing & Sports Medicine Committee Report to the
USA Powerlifting National Governing Body Meeting
July 12, 2002
Sports Medicine Committee Report
This committee was created in 1994. Since that time this committee has been charged with addressing the sports medicine-related issues of USA Powerlifting along with admitting various health professionals after their credentials have been verified and approved to the Sports Medicine Committee (SMC) to assist and treat our athletes at our National and International competitions. Over the years we have treated approximately 3100 athletes. The ailments we have treated are mainly neuromusculoskeletal in nature, with an almost equal spread between treating acute and chronic injuries. The current percentages of injuries that we treat are as follows:
1. Lower back injuries: 53%
2. Cervical injuries: 15%
3. Shoulder injuries: 11%
4. Knee injuries: 11%
5. Miscellaneous injuries: 10%
We also just recently added 4 new doctors to the SMC in key areas of the country. If you know of any doctors or other health professionals that may be interested in joining the SMC, please feel free to give them my number or email (see Administration page) and the SMC will get in contact with them.
Drug Testing Committee Report
As the Drug Testing Committee for USA Powerlifting, we have the responsibility of overseeing and directing all the drug testing done in this organization. The following is my report for the 2002 NGB Meeting.
1. For 2001 we performed about 700 total drug tests, which when combined with the total membership for 2001, meant 18.4% of our membership had been tested. (Note: A few of our athletes that were tested in 2001 had been tested more than once last year.) Of these 700 tests, we had 25 positive A samples, with 2 of these requesting their B sample to be tested as well. These B samples were also positive and failed for the same illegal substances as the respective A sample did for that athlete.
Of these 25 A sample positives, the break down was as follows for the type of substances these samples failed for (several of these 25 positives failed for multiple substances):
Nandrolone: 88%
T/E Ratio: 12%
Epitestosterone > 200 ng/ml: 12%
Stanozolol: 8%
Methandienone: 8%
Pseudoephedrine: 4%
Oxymetholone: 4%
Methenolone: 4%
Last year I had reported that the T/E ratios that had been reported were quite large for a few of the tests. In 2001 the highest we saw was 126 to 1, with the next one at 74 to 1. This contrasts with the year prior when we had levels as high as 411 to 1.
2. During the end of 2001 and the beginning of 2002, we formed the Custodial Board of the USAPL. The Custodial Board (CB) shall hear appeals of failed drug tests by a member of USAPL. After hearing these appeals, the CB will render a decision and report this decision to the President of USAPL. If the athlete wishes to appeal the decision of the CB, they must appeal to the National Office and then the case will go to the Executive Committee if 2/3 of the members agree to review the case. The CB consists of 5 members with the Chairman of the Drug Testing Committee chairing this CB. We heard our first case in February 2002 and have heard a total of 2 cases so far.
3. Quest Diagnostics, our main laboratory for our drug testing program, has changed to a new operating system and has made some changes to its reports that we receive after the drug tests have been processed. We are in the process of working with them to make this transition as smooth as possible.
4. There was a motion at this year's NGB to have USADA do our OMT's for us along with Event testing. While this is an idea that we may entertain in the future, right now we will stay with our current program. One of the reasons for this is cost. They would charge $450-500 per OMT test, plus travel and expenses. Event testing would cost $250-300 per Event test, plus travel and expenses. Right now our main test costs $59 per test and the travel and expenses are usually donated by the volunteer, with some exceptions for OMT's that are done over long distances, where travel is reimbursed. This also means we will continue to utilize the help of USAPL officials to help administer our OMT program. So if you are asked to help, please do so. This will allow us to keep our great drug testing heritage alive and well!!
5. After almost 5 years in the IPF, we have not had ONE drug test failure at the International level!! That is saying something since most of the other Top 5 countries at most of the World Championships have had at least 1 failure at the International level during this same time. Congratulations to USAPL!!
6. Last, but not least, accuracy of test taking. I cannot stress this enough: make sure you dot your "I's" and cross your "T's" before sealing the Chain of Custody document in the lab bag. Read the form 2, 3, 4 times. Take your time. If it is wrong, throw it all out and start over. I would rather you take more time then be in a hurry or not want to do the test over and have it be for an athlete whose results were positive. Athletes: if you are not happy with the procedures of the test being given to you, don't sign the final line and then ask to re-do it. Throw away the test and start all over again. Better to be safe than sorry.
Michael A. Hartle, D.C., D.A.C.B.N., C.C.N., C.C.S.P., C.S.C.S.
USA Powerlifting Executive Committee Board Member
Chairman, USA Powerlifting Sports Medicine Committee
Chairman, USA Powerlifting Drug Testing Committee
|
|
USAPL Suspension
List, Effective May 2002
Name State Offense Date of Off. Length of Suspension
Tim King North CarolinIndebtedness to the Association May 20, 1998 Indefinite Indefinite
Chris Kostas California Indebtedness To The Association - Jul 20, 1998 Indefinite Indefinite
Refusal to do Drug Testing at Meets
Steve Gavin Minnesota Indebtedness To The Association; May 21, 2001 Indefinite Indefinite
Bringing organization into disrepute
Antonio Garcia Colorado Nandrolone (second offense) Sep 23, 2001 Indefinite Indefinite
Ronnie Savoie Louisiana Nandrolone, T/E Ratio 10.3 Jun 20, 1999 3 years Jun 20, 2000
Dustin Maria Colorado Nandrolone Jun 27, 1999 3 years Jun 27, 2000
Hennis Washington Florida Failure To Report For Drug Testing Jul 16, 1999 3 years Jul 16, 2000
Horce Lane Michigan Nandrolone Jul 18, 1999 3 years Jul 18, 2000
Mark O'Shaughnessy Florida Nandrolone, Oxymetholone Sep 12, 1999 3 years Sep 12, 2000
Scott Purto New Mexico Nandrolone Oct 03, 1999 3 years Oct 03, 2000
Greg Faulkenberry South CarolinNandrolone Oct 16, 1999 3 years Oct 16, 2000
Stella Krupinski Virginia Nandrolone Oct 23, 1999 3 years Oct 23, 2000
Michael D. Jones Ohio T/E Ratio 66.6 Nov 13, 1999 3 years Nov 13, 2000
Steven J. Ayre Colorado Nandrolone Nov 13, 1999 3 years Nov 13, 2000
Brett Neuman Wyoming Nandrolone Nov 20, 1999 3 years Nov 20, 2000
Christine Rovnak Idaho Methandienone, T/E Ratio 50.0 Nov 20, 1999 3 years Nov 20, 2000
Andrew Bates Colorado Nandrolone Dec 05, 1999 3 years Dec 05, 2000
Jason Bennett Colorado Nandrolone Dec 05, 1999 3 years Dec 05, 2000
Shane McShane Hawaii T/E Ratio 22.5 Dec 18, 1999 3 years Dec 18, 2000
Zindy Coss Alaska Nandrolone Dec 27, 1999 3 years Dec 27, 2000
Debbie Christensen Utah Methyltestosterone Jan 17, 2000 3 years Jan 17, 2000
Michael A. Bradley Maryland T/E Ratio 9.2 Jan 15, 2000 3 years Jan 15, 2000
Tom Conklin Wisconsin Nandrolone Jan 22, 2000 3 years Jan 22, 2000
Lonnie Coxsey Colorado T/E Ratio 4.4 Feb 13, 2000 3 years Feb 13, 2000
Terry Nelson North Dakota Nandrolone Mar 04, 2000 3 years Mar 04, 2000
Jeff A. Peshek Ohio Nandrolone Mar 11, 2000 3 years Mar 11, 2000
Chris Scott Ohio Nandrolone, Stanozolol, T/E Ratio 87.9 Mar 11, 2000 3 years Mar 11, 2000
Jeff Cook Ohio Nandrolone, T/E Ratio 20.4 Mar 11, 2000 3 years Mar 11, 2000
Jason Buccek Minnesota Nandrolone Mar 18, 2000 3 years Mar 18, 2000
Mary Jacobson California Failure to report for testing Apr 08, 2000 3 years Apr 08, 2000
John Wagner Pennsylvania Methandienone Apr 15, 2000 3 years Apr 15, 2000
Al Dawson Washington Nandrolone, Methandienone, Oxymetholone Apr 15, 2000 3 years Apr 15, 2000
T/E ratio 181.1
Jeffrey Boutot Maine Nandrolone Apr 22, 2000 3 years Apr 22, 2000
Leonard Brightwell Virginia Nandrolone Apr 29, 2000 3 years Apr 29, 2000
Alex Galant Colorado Nandrolone May 06, 2000 3 years May 06, 2000
Adam Stiverson Michigan Nandrolone May 06, 2000 3 years May 06, 2000
Kenneth Tuohey Virginia Nandrolone May 13, 2000 3 years May 13, 2000
Jerry Willis Michigan Nandrolone May 13, 2000 3 years May 13, 2000
Joe Thompson Wyoming Methandienone, Nandrolone May 20, 2000 3 years May 20, 2000
Chris Berry Idaho Nandrolone May 20, 2000 3 years May 20, 2000
Joe Bider Texas Boldenone, Ephedrine, Pseudoephedrine Jun 11, 2000 3 years Jun 11, 2000
Chris Brigham California Methyltesterone Jun 17, 2000 3 years Jun 17, 2000
James McGlynn Florida Nandrolone, Methenolone, Stanozolol Jul 08, 2000 3 years Jul 08, 2000
T/E Ratio 150.1
Jeff Himmelrick Nebraska Boldenone Jul 16, 2000 3 years Jul 16, 2000
Scott Brone California Nandrolone Oct 28, 2000 3 years Oct 28, 2000
Jeffery Hunter New Mexico Nandrolone, T/E Ratio 9.5 Oct 28, 2000 3 years Oct 28, 2000
Ralph Kiebach Ohio Nandrolone, T/E Ratio 51.7 Nov 12, 2000 3 years Nov 12, 2000
Thomas Lamoureux MassachusettsNandrolone, T/E Ratio 8.5 Nov 19, 2000 3 years Nov 19, 2000
Jeff Diederich Kentucky Nandrolone, Oxymetholone Dec 02, 2000 3 years Dec 02, 2000
Jeff Holzbauer Illinois Nandrolone Dec 02, 2000 3 years Dec 02, 2000
Greg Zoeller Illinois Methandienone, Oxymetholone, T/E Ratio 408.0 Dec 02, 2000 3 years Dec 02, 2000
George L Ferrell Virginia Fluoxymesterone, Methandienone, Nandrolone, Dec 09, 2000 3 years Dec 09, 2000
T/E Ratio 29.1
Jeremy Biewer Minnesota Failure to report for testing Jan 20, 2001 3 years Jan 20, 2000
Paul F Unis Colorado Nandrolone, T/E Ratio 22.7 Jan 28, 2001 3 years Jan 28, 2000
Steve T Fergen South Dakota Nandrolone Feb 10, 2001 3 years Feb 10, 2000
CJ Salas Nebraska Nandrolone Feb 10, 2001 3 years Feb 10, 2000
David Pierce Michigan Nandrolone Feb 10, 2001 3 years Feb 10, 2000
Eric Sampson Wisconsin Nandrolone Feb 17, 2001 3 years Feb 17, 2000
Warren Fahrenfeld New Jersey Nandrolone, Epitestosterone Mar 24, 2001 3 years Mar 24, 2000
James Rictor Oregon Nandrolone, Stanozolol Mar 24, 2001 3 years Mar 24, 2000
Patrick Gratton Missouri T/E Ratio 74.7 Mar 31, 2001 3 years Mar 31, 2000
Matthew Hebert Louisiana Nandrolone Apr 01, 2001 3 years Apr 01, 2000
Boomer Fleming Hawaii Nandrolone, Methandienone Jun 30, 2001 3 years Jun 30, 2000
Jason Berkowitz Pennsylvania Nandrolone Apr 29, 2001 3 years Apr 29, 2000
Robert Abfalter Michigan Nandrolone Jul 28, 2001 3 years Jul 28, 2000
Jacob W Heglar Virginia Nandrolone Oct 21, 2001 3 years Oct 21, 2000
Tim E Geyer Michigan Nandrolone Oct 27, 2001 3 years Oct 27, 2000
Brett J Polofsky Rhode Island Nandrolone, Oxymetholone Nov 17, 2001 3 years Nov 17, 2000
Douglas D Mounkes Kansas Nandrolone, Epitestosterone Nov 17, 2001 3 years Nov 17, 2000
Elizibeth Volk Texas Nandrolone Nov 17, 2001 3 years Nov 17, 2000
Theresa J Fish Wisconsin Nandrolone, Stanozolol Nov 26, 2001 3 years Nov 26, 2000
Toe Preston Hawaii Nandrolone Dec 08, 2001 3 years Dec 08, 2000
Karen C Phillips Virginia Nandrolone, Methandienone,T/E ratio 126.4 Dec 08, 2001 3 years Dec 08, 2000
Garnet C Boudreau Maine Methenolone; T/E ratio 57.5 Dec 08, 2001 3 years Dec 08, 2000
Joshua McMillan Michigan Boldenone Feb 02, 2002 3 years Feb 02, 2000
John Onorato Colorado Nandrolone Feb 10, 2002 3 years Feb 10, 2000
Jim Thompson Montana Boldenone; T/E ratio 44.9 Feb 23, 2002 3 years Feb 23, 2000
Ralph Buckles Minnesota Nandrolone, Epitestosterone, T/E ratio +6.0 Mar 16, 2002 3 years Mar 16, 2000
Dwayne Poucher Florida Nandrolone Mar 24, 2002 3 years Mar 24, 2000
Antonio Lanzellotta New Jersey Failure to report for testing Apr 27, 2002 3 years Apr 27, 2000
